logo
8 best Apple Prime Day deals you can still shop on Amazon Canada— major savings on AirPods, Apple Watch Series 10, iPads and more

8 best Apple Prime Day deals you can still shop on Amazon Canada— major savings on AirPods, Apple Watch Series 10, iPads and more

Yahoo11-07-2025
Amazon Prime Day 2025 is already on day 3 — and for those looking to snag a deal (or several) on Apple devices, we have good news: AirPods, Apple Watches, iPads and more Apple gadgets are on sale on Amazon Canada.
Apple devices, as we all know, rarely go on sale, especially outside of Black Friday and Boxing Day. So, unless you're willing to wait until the end of November to save some cash, we recommend checking out what Prime Day 2025 has to offer.
Below, we've rounded up the best — and steepest — deals on Apple devices, including both AirPods and AirPods Max, the Apple Watch SE and Series 10 and more. Trust us when we say: these deals will sell out quickly, so if you see something that catches your eye, it's in your best interest to act fast.
Amazon Prime Day, of course, is a Prime member-exclusive event, meaning that if you want to take advantage of the deals, you'll need a Prime membership. Not yet a member?
With six hours of listening time on a single charge and up to 30 hours when using the MagSafe Charging Case (included), the AirPods boast impressive battery life. It comes with four silicone tips that help you achieve a secure and comfortable fit, while also keeping sound in and external noise out.
The AirPods resist dust, sweat, and water, making them suitable for sweaty workouts or outdoor activities while also providing intelligent noise control. It also features an H2 chip, which provides deep, immersive sound with rich bass and overall improved definition.
The Apple Watch Series 10 is an on-the-go command centre for calls and texts, Apple Pay, and dozens of health and fitness metrics.
The watch measures your blood oxygen levels, takes an ECG, tracks your sleep stages, and offers the same spot-on calorie and heart rate monitoring that you've come to expect from Apple devices.The Apple AirPods 4 deliver up to 30 hours of listening time — and up to 20 hours when Active Noise Cancellation is enabled.
They're sweat, dust and water-resistant, offering users Adaptive Audio and Transparency mode. Plus, the powerful H2 chip delivers clearer calls with Voice Isolation, making the AirPods great for phone calls and work meetings.
The latest 11-inch iPad is perfect for everyday use, whether you're watching TV shows, writing notes, browsing the web or staying up to date on socials. Its bright Liquid Retina display will make everything look crisp and clear, and the battery will last all day without needing a charge.
It's compatible with the Apple Pencil and Magic Keyboard (sold separately), so you can take notes, draw or get work done efficiently.
The Apple AirPods Max feature personalized Spatial Audio with dynamic head tracking for surround-like sound and pro-level noise-cancellation to remove unwanted noise, making them a fantastic option for air travel, commuting and office work.
The watch has a built-in compass and is water-resistant up to 50 metres, so you can hit the beach without worry this summer. It will alert you if your heart rate is abnormally high or low and signal irregular heart rhythm notifications. Additionally, the Apple Watch can detect if you've taken a hard fall and automatically call emergency services if needed.
A must-have device for modern-day wellness, the smartwatch tracks every way you get your heart going, including swimming, yoga, dancing, cycling and more.
This powerful Apple iPad Mono gives you the ultimate iPad experience — the 8.3" iPad features an ultrafast A17 Pro chip, 12MP Ultra Wide front camera with Center Stage, USB-C connectivity, super fast Wi-Fi 6E and compatibility with Apple Pencil Pro.
Never lose your keys, bag or wallet again. Apple AirTags will help you keep track of your stuff using the "Find My" app on your iPhone or iPad.
Setup is quick and easy with just one tap, and you can play a sound or ask Siri to help you locate your item. If it's nearby, "Precision Finding" will guide you right to it. If it's farther away, the "Find My" network can help you track it down privately and securely.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Thermo Fisher shares climb as Q2 top and bottom line exceed estimates
Thermo Fisher shares climb as Q2 top and bottom line exceed estimates

Yahoo

time24 minutes ago

  • Yahoo

Thermo Fisher shares climb as Q2 top and bottom line exceed estimates

-- Thermo Fisher Scientific Inc (NYSE:TMO) reported second-quarter earnings that topped expectations, with revenue also coming in ahead of forecasts. The company reported adjusted EPS of $5.36, beating the analyst estimate of $5.23. Revenue rose 3% from a year earlier to $10.85 billion, above the $10.68 billion consensus. Shares in the medical equipment maker were up 2.3% in premarket trading Wednesday as of 06:06 ET. 'Our exceptional team continues to execute at a high level, enabling customer success while navigating the macroenvironment," said Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific. Adjusted operating income reached $2.38 billion, slightly up from $2.35 billion in the same period last year. Adjusted operating margin slipped to 21.9% from 22.3% a year ago. Related articles Thermo Fisher shares climb as Q2 top and bottom line exceed estimates These Under-the-Radar Stocks Offer Better Risk-Reward Ratio Than Nvidia If Powell goes, does Fed trust go with him?

Wolverine Worldwide Announces Second Quarter Fiscal 2025 Conference Call for August 6, 2025
Wolverine Worldwide Announces Second Quarter Fiscal 2025 Conference Call for August 6, 2025

Yahoo

time24 minutes ago

  • Yahoo

Wolverine Worldwide Announces Second Quarter Fiscal 2025 Conference Call for August 6, 2025

ROCKFORD, Mich., July 23, 2025--(BUSINESS WIRE)--Wolverine World Wide, Inc. (NYSE: WWW) today announced that it expects to report its second quarter fiscal 2025 financial results on Wednesday, August 6, 2025, at approximately 6:30 a.m. ET. Following the press release, the Company will host a conference call at 8:30 a.m. ET to review results and discuss current business trends. Investors and analysts interested in joining the call are invited to dial 1-800-715-9871 (international callers, please dial 1-646-307-1963) approximately five minutes prior to the start of the call. The conference call will be broadcast live and accessible under "Webcasts & Presentations" in the Investor Relations section of A recorded replay of the call will be available shortly after the conclusion of the call and remain available until August 13, 2025. To access the telephone replay, dial 1-800-770-2030 (international callers, please dial 1-609-800-9909). The access code for the replay is 9927992. ABOUT WOLVERINE WORLDWIDE Founded in 1883, Wolverine World Wide, Inc. (NYSE:WWW) is one of the world's leading designers, marketers, and licensors of branded casual footwear and apparel, performance outdoor and athletic footwear and apparel, kids' footwear, industrial work boots and apparel, and uniform footwear. The Company's portfolio includes Merrell®, Saucony®, Sweaty Betty®, Hush Puppies®, Wolverine®, Chaco®, Bates®, HYTEST®, and Stride Rite®. Wolverine Worldwide is also the global footwear licensee of the popular brands Cat® and Harley-Davidson®. Based in Rockford, Michigan, for more than 140 years, the Company's products are carried by leading retailers in the U.S. and globally in approximately 170 countries and territories. Wolverine Worldwide is a Great Place to Work® Certified™ company. For additional information, please visit our website, View source version on Contacts Jared Filippone, CFA (616) 894-8576 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs

Yahoo

time24 minutes ago

  • Yahoo

BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs

FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable Injector for subcutaneous delivery of complex biologics. The selection of BD Libertas™ Wearable Injector for this pharma-sponsored trial follows successful outcomes from more than 50 BD-conducted pre-clinical and clinical studies, including a device clinical study demonstrating excellent performance with 100% of study participants stating they would likely use the BD Libertas™ Wearable Injector if prescribedi,ii. The pharma-sponsored combination product clinical trial represents a significant advancement in accelerating innovation in drug-device combination products that provide greater flexibility for patients, including potential conversion from infused medications that require patients to travel to a hospital or clinic to more convenient patient care in various settings, including self-injection at home. "This trial demonstrates BD's commitment to helping pharma companies by advancing large-volume injection science, ensuring therapies are accessible and patient friendly by offering more efficient and convenient options for biologics," said Patrick Jeukenne, worldwide president of BD Pharmaceutical Systems. "BD's enhanced testing capabilities acquired through ZebraSci and the proven capabilities of the BD Libertas™ Wearable Injector technology further position BD as an innovative leader in drug delivery." The BD Libertas™ Wearable Injector is an innovative, prefilled, patient ready-to-use drug delivery systemiii designed to enable delivery of complex biologics via subcutaneous injection. The biologics market is expected to grow to more than $670 billioniv by 2030 and for pharmaceutical companies developing these complex drugs, the BD Libertas™ Wearable Injector offers a customizable, patient-centric solution. The BD Libertas™ Wearable Injector: Supports delivery of high-viscosity biologics (up to 50 centipoise), enabling a wide range of subcutaneous therapies Is offered in 2 to 5 mL and 5 to 10 mL configurations providing flexibility for diverse therapeutic requirements Features a fully mechanical, patient ready-to-use design with a simple "peel, stick and click" mechanism, requiring no end-user filling or assemblyiii BD's ongoing validations of fill-finish and final assembly processes with multiple Contract Manufacturing Organizations (CMOs) enable the company to support pharmaceutical partners from development through commercial-scale production. For more information about how BD Libertas™ Wearable Injector is enabling biologic therapy delivery, visit About BD Libertas™ Wearable InjectorBD Libertas™ Wearable Injector is a product in development; some statements are forward looking and are subject to a variety of risks and uncertainties. BD Libertas™ Wearable Injector is a device component intended for drug-device combination products and not subject to FDA 510(k) clearance or separate EU CE mark certification. About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit or connect with us on LinkedIn at X (formerly Twitter) @BDandCo or Instagram @becton_dickinson. Contacts: Media: Investors: Fallon McLoughlin Adam Reiffe BD Corporate Communications BD Investor Relations 201.258.0361 201.847.6927 i Early feasibility clinical study of investigational BD Libertas™ Wearable Injector (WI) evaluated 5ml, non- Newtonian ~8cP subcutaneous placebo injections in 52 healthy adult subjects for functionality, tissue effects, subject tolerability (100mm Visual Analog Scale (VAS)) and acceptability (questionnaires with 5-point Likert or yes /no responses). Tissue effects were measured from WI removal post-injection through 24 hours with calipers (wheals) or graded on a 5-point scale (erythema, bleeding) from 0-none to 4-severe, significant, respectively. Where tissue effects were observed, the majority (>50%) were resolved within 60 minutes and all within 24 hours. Subject pain (100mm VAS) peaked mid-injection (mean 9.1mm, SD 13.4) and rapidly resolved within 30 minutes (mean 0 .4mm, SD 2.6). Subjects found acceptable (Likert agree + strongly agree or yes responses) their peak pain (≥90.2%), injection site appearance (≥92.2% ).ii Woodley, W. D. et al. Clinical Evaluation of an Investigational 5ml Wearable Injector in Healthy Human Subjects. Clin Transl Sci. 2021 May;14(3):859-869. Pharma filled and assemblediv Mordor Intelligence (2025). Biologics Market Size - Industry Report on Share, Growth Trends & Forecasts Analysis (2025 - 2030). View original content to download multimedia: SOURCE BD (Becton, Dickinson and Company) Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store